The successful management of acute promyelocytic leukemia during pregnancy: a case report

References

• Celsing F, Ekman G, Granström L, et al. Caesarean section in previously untreated acute promyelocytic leukaemia. Report of two patients. Eur J Obstet Gynecol Reprod Biol. 2000;91(1):41–42. doi:10.1016/s0301-2115(99)00254-7
   PubMed Web of Science ®Google Scholar
• Song X, Peng Y, Wang X, et al. Incidence, survival, and risk factors for adults with acute myeloid leukemia not otherwise specified and acute myeloid leukemia with recurrent genetic abnormalities: analysis of the surveillance, epidemiology, and end results (SEER) database, 2001-2013. Acta Haematol. 2018;139(2):115–127. doi:10.1159/000486228
   PubMed Web of Science ®Google Scholar
• Sanz MA, Fenaux P, Tallman MS, et al. Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet. Blood. 2019;133(15):1630–1643. doi:10.1182/blood-2019-01-894980
   PubMed Web of Science ®Google Scholar
• Lo-Coco F, Avvisati G, Vignetti M, et al. Retinoic acid and arsenic trioxide for acute promyelocytic leukemia. N Engl J Med. 2013;369(2):111–121. doi:10.1056/NEJMoa1300874
   PubMed Web of Science ®Google Scholar
• Yang D, Hladnik L. Treatment of acute promyelocytic leukemia during pregnancy. Pharmacotherapy. 2009;29(6):709–724. doi:10.1592/phco.29.6.709
   PubMed Web of Science ®Google Scholar
• Waalkes MP, Ward JM, Diwan BA. Induction of tumors of the liver, lung, ovary and adrenal in adult mice after brief maternal gestational exposure to inorganic arsenic: promotional effects of postnatal phorbol ester exposure on hepatic and pulmonary, but not dermal cancers. Carcinogenesis. 2004;25(1):133–141. doi:10.1093/carcin/bgg181
   PubMed Web of Science ®Google Scholar
• Report NRC (US) S to U the 1999, A in DW. Experimental studies. Washington (DC): National Academies Press, 2001.
   Google Scholar
• Culligan DJ, Merriman L, Kell J, et al. The management of acute promyelocytic leukemia presenting during pregnancy. Clin Leuk. 2007;1(3):183–191. doi:10.3816/CLK.2007.n.006
   Google Scholar
• Santolaria A, Perales A, Montesinos P, et al. Acute promyelocytic leukemia during pregnancy: a systematic review of the literature. Cancers (Basel). 2020;12(4):968. doi:10.3390/cancers12040968
   PubMed Web of Science ®Google Scholar
• Iland HJ, Bradstock K, Supple SG, et al. All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4). Blood. 2012;120(8):1570–1580; quiz 1752. doi:10.1182/blood-2012-02-410746
   PubMed Web of Science ®Google Scholar
• Sanz MA, Grimwade D, Tallman MS, et al. Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. Blood. 2009;113(9):1875–1891. doi:10.1182/blood-2008-04-150250
   PubMed Web of Science ®Google Scholar
• Siu BL, Alonzo MR, Vargo TA, et al. Transient dilated cardiomyopathy in a newborn exposed to idarubicin and all-trans-retinoic acid (ATRA) early in the second trimester of pregnancy. Int J Gynecol Cancer. 2002;12(4):399–402. doi:10.1046/j.1525-1438.2002.01128.x
   PubMed Web of Science ®Google Scholar
• Reynoso EE, Huerta F. Acute leukemia and pregnancy–fatal fetal outcome after exposure to idarubicin during the second trimester. Acta Oncol. 1994;33(6):709–710.
   PubMed Web of Science ®Google Scholar
• Claahsen HL, Semmekrot BA, van Dongen PW, et al. Successful fetal outcome after exposure to idarubicin and cytosine-arabinoside during the second trimester of pregnancy–a case report. Am J Perinatol. 1998;15(5):295–297. doi:10.1055/s-2007-993946
   PubMed Web of Science ®Google Scholar
• Shah G, Mikhail FM, Erba HP, et al. Omission of maintenance in patients with high-risk acute promyelocytic leukemia (APL) in the era of ATRA/arsenic consolidation. Blood. 2018;132(Supplement 1):5192–5192. doi:10.1182/blood-2018-99-114872
   Google Scholar
• Liu S (, Fletcher L, Traer E. Consolidation of high-risk acute promyelocytic leukemia (APL) in community infusion centers: a single center experience. Blood. 2022;140(Supplement 1):11708–11709. doi:10.1182/blood-2022-159810
   Google Scholar
• Altman JK, Rademaker A, Cull E, et al. Administration of ATRA to newly diagnosed patients with acute promyelocytic leukemia is delayed contributing to early hemorrhagic death. Leuk Res. 2013;37(9):1004–1009. doi:10.1016/j.leukres.2013.05.007
   PubMed Web of Science ®Google Scholar
• Breccia M, Molica M, Efficace F, et al. Pregnancy in acute promyelocytic leukaemia after front-line therapy with arsenic trioxide and all-trans retinoic acid. Br J Haematol. 2014;167(3):428–430. doi:10.1111/bjh.12995
   PubMed Web of Science ®Google Scholar
• Golub MS, Macintosh MS, Baumrind N. Developmental and reproductive toxicity of inorganic arsenic: animal studies and human concerns. J Toxicol Environ Health B Crit Rev. 1998;1(3):199–241. doi:10.1080/10937409809524552
   PubMed Web of Science ®Google Scholar
• He W, Greenwell RJ, Brooks DM, et al. Arsenic exposure in pregnant mice disrupts placental vasculogenesis and causes spontaneous abortion. Toxicol Sci. 2007;99(1):244–253. doi:10.1093/toxsci/kfm162
   PubMed Web of Science ®Google Scholar
• Naujokas MF, Anderson B, Ahsan H, et al. The broad scope of health effects from chronic arsenic exposure: update on a worldwide public health problem. Environ Health Perspect. 2013;121(3):295–302. doi:10.1289/ehp.1205875
   PubMed Web of Science ®Google Scholar
• Ahmad SA, Sayed MH, Barua S, et al. Arsenic in drinking water and pregnancy outcomes. Environ Health Perspect. 2001;109(6):629–631. doi:10.1289/ehp.01109629
   PubMed Web of Science ®Google Scholar
• Cochet C, Simonet M, Cattin J, et al. Arsenic trioxide treatment during pregnancy for acute promyelocytic leukemia in a 22-year-old woman. Case Rep Hematol. 2020;2020:3686584.
   PubMed Web of Science ®Google Scholar
• Guo M, Lv J, Chen X, et al. Arsenic trioxide therapy during pregnancy: ATO and its metabolites in maternal blood and amniotic fluid of acute promyelocytic leukemia patients. Front Oncol. 2022;12:887026. doi:10.3389/fonc.2022.887026
   PubMed Web of Science ®Google Scholar
• Milligan DW, Grimwade D, Cullis JO, et al. Guidelines on the management of acute myeloid leukaemia in adults. Br J Haematol. 2006;135(4):450–474. doi:10.1111/j.1365-2141.2006.06314.x
   PubMed Web of Science ®Google Scholar
• Fei F, Faye-Petersen OM, Vachhani P, et al. Acute promyelocytic leukemia during pregnancy: a case report and 10-year institutional review of hematologic malignancies during pregnancy. Pathol Res Pract. 2019;215(12):152672. doi:10.1016/j.prp.2019.152672
   PubMed Web of Science ®Google Scholar